English

Elliptic Laboratories ASA

ESEF

Report (type unavailable) · filed 2025-05-08

Annual consolidated revenue for 2024: about NOK 131.9M, using the latest reported figures. The previous period, 2023, was about NOK 68.32M.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest fiscal year

Revenue

132 million NOK

2024 · NOK

Exact inputs and evidence

Revenue: 131914000 NOK Source

Operating margin

3.57%

2024 · %

Exact inputs and evidence

Operating Income: 4710000 NOK Source
Revenue: 131914000 NOK Source

Operating cash flow

-10.6 million NOK

2024 · NOK

Exact inputs and evidence

Operating Cash Flow: -10607000 NOK Source

Free cash flow

-10.6 million NOK

2024 · NOK

Exact inputs and evidence

Operating Cash Flow: -10607000 NOK Source
Capital Expenditure: 0 NOK Source

Cash and cash equivalents: 76.4 million NOK 2024-12-31 Source
Exact value

76390000 NOK
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-05-08.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2024-12-31
Operating income: 5 of 11 periods available· newest 2024-12-31
Net income: 5 of 11 periods available· newest 2024-12-31
Operating cash flow: 5 of 11 periods available· newest 2024-12-31
Capital expenditure: 3 of 11 periods available· newest 2024-12-31
Total assets: 5 of 11 periods available· newest 2024-12-31
Total liabilities: 3 of 11 periods available· newest 2023-12-31
Current assets: 5 of 11 periods available· newest 2024-12-31
Current liabilities: 5 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+93.1%

Prior period

NOK 68.32 million

2023-01-01 – 2023-12-31
Current period

NOK 131.91 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

131914000 − 68321000 = 63593000 NOK

68321000 NOK · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
131914000 NOK · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Year-over-year change in Revenue: 63593000 NOK Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 131914000 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3756315 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 Input fundies:Revenue: 68321000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3756951 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.
Net income
+NOK 47.59 million

Prior period

−NOK 37.96 million

2023-01-01 – 2023-12-31
Current period

NOK 9.63 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

9627000 − -37964000 = 47591000 NOK

-37964000 NOK · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
9627000 NOK · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Year-over-year change in Net income: 47591000 NOK Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 9627000 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3799475 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 Input fundies:NetIncome: -37964000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3800142 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+NOK 27.49 million

Prior period

−NOK 38.1 million

2023-01-01 – 2023-12-31
Current period

−NOK 10.61 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-10607000 − -38100000 = 27493000 NOK

-38100000 NOK · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-10607000 NOK · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Year-over-year change in Operating cash flow: 27493000 NOK Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -10607000 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3996192 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 Input fundies:OperatingCashFlow: -38100000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3996900 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

NOK 514,000

2023-01-01 – 2023-12-31
Current period

NOK 0

2024-01-01 – 2024-12-31

Exact inputs and evidence

0 − 514000 = -514000 NOK

514000 NOK · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
0 NOK · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Year-over-year change in Capital expenditure: -514000 NOK Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3999372 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 514000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#4000057 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue NOK 131.91 million 100% of revenue
Operating costs Derived NOK 127.2 million 96% of revenue
Operating income NOK 4.71 million 3.6% of revenue
Tax, interest and other Derived −NOK 4.92 million −3.7% of revenue
Net income NOK 9.63 million 7.3% of revenue

Cash

Operating cash flow −NOK 10.61 million −8% of revenue
Capital expenditure NOK 0 0% of revenue
Free cash flow Derived −NOK 10.61 million −8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 133% of revenue.
2021 Operating loss: operating costs were 120% of revenue.
2022 Operating loss: operating costs were 181% of revenue.
2023 Operating loss: operating costs were 173% of revenue.
2024 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	30215000	40317000 Derived	-10102000	2455000 Derived	-12557000	Unavailable	Source 2020-01-01 – 2020-12-31: 30215000 NOK Inspect Revenue Open source 2020-01-01 – 2020-12-31: -10102000 NOK Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -12557000 NOK Inspect Net Income Open source 2020-01-01 – 2020-12-31: -6678000 NOK Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	54598000	65738000 Derived	-11140000	16000 Derived	-11156000	Unavailable	Source 2021-01-01 – 2021-12-31: 54598000 NOK Inspect Revenue Open source 2021-01-01 – 2021-12-31: -11140000 NOK Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -11156000 NOK Inspect Net Income Open source 2021-01-01 – 2021-12-31: -10822000 NOK Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	52062000	94193000 Derived	-42131000	-9548000 Derived	-32583000	-17341000 Derived	Source 2022-01-01 – 2022-12-31: 52062000 NOK Inspect Revenue Open source 2022-01-01 – 2022-12-31: -42131000 NOK Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -32583000 NOK Inspect Net Income Open source 2022-01-01 – 2022-12-31: -17341000 NOK Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 0 NOK Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	68321000	118210000 Derived	-49889000	-11925000 Derived	-37964000	-38614000 Derived	Source 2023-01-01 – 2023-12-31: 68321000 NOK Inspect Revenue Open source 2023-01-01 – 2023-12-31: -49889000 NOK Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -37964000 NOK Inspect Net Income Open source 2023-01-01 – 2023-12-31: -38100000 NOK Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 514000 NOK Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	131914000	127204000 Derived	4710000	-4917000 Derived	9627000	-10607000 Derived	Source 2024-01-01 – 2024-12-31: 131914000 NOK Inspect Revenue Open source 2024-01-01 – 2024-12-31: 4710000 NOK Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 9627000 NOK Inspect Net Income Open source 2024-01-01 – 2024-12-31: -10607000 NOK Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 0 NOK Inspect Capital Expenditure Open source

Amounts are exact, in NOK.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

NOK 131.9M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(NOK)	Source evidence
20202020-12-31	Revenue	30215000	Revenue: 30215000 Open source
20212021-12-31	Revenue	54598000	Revenue: 54598000 Open source
20222022-12-31	Revenue	52062000	Revenue: 52062000 Open source
20232023-12-31	Revenue	68321000	Revenue: 68321000 Open source
20242024-12-31	Revenue	131914000	Revenue: 131914000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

93.1% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 30215000 Open source
20212021-12-31	Year over year	80.7%	Revenue: 54598000 Open source Revenue: 30215000 Open source
20222022-12-31	Year over year	-4.6%	Revenue: 52062000 Open source Revenue: 54598000 Open source
20232023-12-31	Year over year	31.2%	Revenue: 68321000 Open source Revenue: 52062000 Open source
20242024-12-31	Year over year	93.1%	Revenue: 131914000 Open source Revenue: 68321000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3.6% 2024

Net margin 7.3% 2024

Free cash flow margin -8% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-33.4%	Operating Income: -10102000 Open source Revenue: 30215000 Open source
20212021-12-31	Operating margin	-20.4%	Operating Income: -11140000 Open source Revenue: 54598000 Open source
20222022-12-31	Operating margin	-80.9%	Operating Income: -42131000 Open source Revenue: 52062000 Open source
20232023-12-31	Operating margin	-73%	Operating Income: -49889000 Open source Revenue: 68321000 Open source
20242024-12-31	Operating margin	3.6%	Operating Income: 4710000 Open source Revenue: 131914000 Open source
20202020-12-31	Net margin	-41.6%	Net Income: -12557000 Open source Revenue: 30215000 Open source
20212021-12-31	Net margin	-20.4%	Net Income: -11156000 Open source Revenue: 54598000 Open source
20222022-12-31	Net margin	-62.6%	Net Income: -32583000 Open source Revenue: 52062000 Open source
20232023-12-31	Net margin	-55.6%	Net Income: -37964000 Open source Revenue: 68321000 Open source
20242024-12-31	Net margin	7.3%	Net Income: 9627000 Open source Revenue: 131914000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 30215000 Open source Operating Cash Flow: -6678000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 54598000 Open source Operating Cash Flow: -10822000 Open source
20222022-12-31	Free cash flow margin	-33.3%	Revenue: 52062000 Open source Operating Cash Flow: -17341000 Open source Capital Expenditure: 0 Open source
20232023-12-31	Free cash flow margin	-56.5%	Revenue: 68321000 Open source Operating Cash Flow: -38100000 Open source Capital Expenditure: 514000 Open source
20242024-12-31	Free cash flow margin	-8%	Revenue: 131914000 Open source Operating Cash Flow: -10607000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

NOK -10.6M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(NOK)	Source evidence
20202020-12-31	Operating cash flow	-6678000	Operating Cash Flow: -6678000 Open source
20212021-12-31	Operating cash flow	-10822000	Operating Cash Flow: -10822000 Open source
20222022-12-31	Operating cash flow	-17341000	Operating Cash Flow: -17341000 Open source
20232023-12-31	Operating cash flow	-38100000	Operating Cash Flow: -38100000 Open source
20242024-12-31	Operating cash flow	-10607000	Operating Cash Flow: -10607000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

NOK -10.6M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(NOK)	Source evidence
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -6678000 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -10822000 Open source
20222022-12-31	Free cash flow	-17341000	Operating Cash Flow: -17341000 Open source Capital Expenditure: 0 Open source
20232023-12-31	Free cash flow	-38614000	Operating Cash Flow: -38100000 Open source Capital Expenditure: 514000 Open source
20242024-12-31	Free cash flow	-10607000	Operating Cash Flow: -10607000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2020-12-31	Liabilities / assets	Not reported	Total Assets: 218722000 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 371356000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 347732000 Open source
2023-12-31	Liabilities / assets	Not reported	Total Assets: 348203000 Open source
2024-12-31	Liabilities / assets	Not reported	Total Assets: 361026000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.83× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	8.93×	Current Assets: 121601000 Open source Current Liabilities: 13616000 Open source
20212021-12-31	Current assets / current liabilities	14.67×	Current Assets: 264949000 Open source Current Liabilities: 18056000 Open source
20222022-12-31	Current assets / current liabilities	13.13×	Current Assets: 225619000 Open source Current Liabilities: 17179000 Open source
20232023-12-31	Current assets / current liabilities	7.45×	Current Assets: 185642000 Open source Current Liabilities: 24926000 Open source
20242024-12-31	Current assets / current liabilities	7.83×	Current Assets: 195451000 Open source Current Liabilities: 24958000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−NOK 12.56 million Exact value Exact value: -12557000 NOK 2020-01-01 – 2020-12-31: -12557000 NOK Inspect Net Income Open source Share or cite Citation for Net Income · Elliptic Laboratories ASA · 2020-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Net Income: -12557000 NOK Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=NOK&dimensions= Input fundies:NetIncome: -12557000 NOK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2021-12-31/ESEF/NO/0/eip-2021-12-31-en.zip#3480398 Filing: 5493001KJTIIGC8Y1R12-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 6.68 million Exact value Exact value: -6678000 NOK 2020-01-01 – 2020-12-31: -6678000 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Elliptic Laboratories ASA · 2020-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Operating Cash Flow: -6678000 NOK Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -6678000 NOK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2021-12-31/ESEF/NO/0/eip-2021-12-31-en.zip#3652086 Filing: 5493001KJTIIGC8Y1R12-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−NOK 11.16 million Exact value Exact value: -11156000 NOK 2021-01-01 – 2021-12-31: -11156000 NOK Inspect Net Income Open source Share or cite Citation for Net Income · Elliptic Laboratories ASA · 2021-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Net Income: -11156000 NOK Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=NOK&dimensions= Input fundies:NetIncome: -11156000 NOK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2022-12-31/ESEF/NO/2/eip-2022-12-31-en.zip#4104283 Filing: 5493001KJTIIGC8Y1R12-2022-12-31-ESEF-NO-2 The citation records this snapshot. The page link may show a newer release later.	−NOK 10.82 million Exact value Exact value: -10822000 NOK 2021-01-01 – 2021-12-31: -10822000 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Elliptic Laboratories ASA · 2021-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Operating Cash Flow: -10822000 NOK Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -10822000 NOK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2022-12-31/ESEF/NO/2/eip-2022-12-31-en.zip#4268334 Filing: 5493001KJTIIGC8Y1R12-2022-12-31-ESEF-NO-2 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−NOK 32.58 million Exact value Exact value: -32583000 NOK 2022-01-01 – 2022-12-31: -32583000 NOK Inspect Net Income Open source Share or cite Citation for Net Income · Elliptic Laboratories ASA · 2022-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Net Income: -32583000 NOK Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=NOK&dimensions= Input fundies:NetIncome: -32583000 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2023-12-31/ESEF/NO/1/eip-2023-12-31-en.zip#4672015 Filing: 5493001KJTIIGC8Y1R12-2023-12-31-ESEF-NO-1 The citation records this snapshot. The page link may show a newer release later.	−NOK 17.34 million Exact value Exact value: -17341000 NOK 2022-01-01 – 2022-12-31: -17341000 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Elliptic Laboratories ASA · 2022-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Operating Cash Flow: -17341000 NOK Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -17341000 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2023-12-31/ESEF/NO/1/eip-2023-12-31-en.zip#4840421 Filing: 5493001KJTIIGC8Y1R12-2023-12-31-ESEF-NO-1 The citation records this snapshot. The page link may show a newer release later.	NOK 0 Exact value Exact value: 0 NOK 2022-01-01 – 2022-12-31: 0 NOK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Elliptic Laboratories ASA · 2022-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Capital Expenditure: 0 NOK Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditure: 0 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2023-12-31/ESEF/NO/1/eip-2023-12-31-en.zip#4843474 Filing: 5493001KJTIIGC8Y1R12-2023-12-31-ESEF-NO-1 The citation records this snapshot. The page link may show a newer release later.	−NOK 17.34 million Calculation and evidence -17341000 − 0 NOK Exact free cash flow: -17341000 NOK 2022-01-01 – 2022-12-31: -17341000 NOK · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 0 NOK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Elliptic Laboratories ASA · 2022-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Free cash flow: -17341000 NOK Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17341000 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2023-12-31/ESEF/NO/1/eip-2023-12-31-en.zip#4840421 Filing: 5493001KJTIIGC8Y1R12-2023-12-31-ESEF-NO-1 Input fundies:CapitalExpenditure: 0 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2023-12-31/ESEF/NO/1/eip-2023-12-31-en.zip#4843474 Filing: 5493001KJTIIGC8Y1R12-2023-12-31-ESEF-NO-1 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−NOK 37.96 million Exact value Exact value: -37964000 NOK 2023-01-01 – 2023-12-31: -37964000 NOK Inspect Net Income Open source Share or cite Citation for Net Income · Elliptic Laboratories ASA · 2023-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Net Income: -37964000 NOK Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=NOK&dimensions= Input fundies:NetIncome: -37964000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3800142 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 38.1 million Exact value Exact value: -38100000 NOK 2023-01-01 – 2023-12-31: -38100000 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Elliptic Laboratories ASA · 2023-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Operating Cash Flow: -38100000 NOK Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -38100000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3996900 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 514,000 Exact value Exact value: 514000 NOK 2023-01-01 – 2023-12-31: 514000 NOK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Elliptic Laboratories ASA · 2023-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Capital Expenditure: 514000 NOK Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditure: 514000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#4000057 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 38.61 million Calculation and evidence -38100000 − 514000 NOK Exact free cash flow: -38614000 NOK 2023-01-01 – 2023-12-31: -38100000 NOK · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 514000 NOK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Elliptic Laboratories ASA · 2023-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Free cash flow: -38614000 NOK Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38100000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3996900 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 514000 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#4000057 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	NOK 9.63 million Exact value Exact value: 9627000 NOK 2024-01-01 – 2024-12-31: 9627000 NOK Inspect Net Income Open source Share or cite Citation for Net Income · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Net Income: 9627000 NOK Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=NOK&dimensions= Input fundies:NetIncome: 9627000 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3799475 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 10.61 million Exact value Exact value: -10607000 NOK 2024-01-01 – 2024-12-31: -10607000 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Operating Cash Flow: -10607000 NOK Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -10607000 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3996192 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 0 Exact value Exact value: 0 NOK 2024-01-01 – 2024-12-31: 0 NOK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Capital Expenditure: 0 NOK Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditure: 0 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3999372 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 10.61 million Calculation and evidence -10607000 − 0 NOK Exact free cash flow: -10607000 NOK 2024-01-01 – 2024-12-31: -10607000 NOK · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 0 NOK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Elliptic Laboratories ASA · 2024-12-31 Elliptic Laboratories ASA (esef:5493001KJTIIGC8Y1R12) Free cash flow: -10607000 NOK Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T03:04:56Z Snapshot: 20b49cdb8d3aac962d7a61614c5cd52341e16c52b59b0b25354756b51503281d Dimensions: Consolidated View: https://fundies.io/companies/esef/5493001KJTIIGC8Y1R12?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10607000 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3996192 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 0 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5493001KJTIIGC8Y1R12/2024-12-31/ESEF/NO/0/eip-2024-12-31-en.zip#3999372 Filing: 5493001KJTIIGC8Y1R12-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

8 filings · 567 latest values · 567 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 5493001KJTIIGC8Y1R12, esef:5493001KJTIIGC8Y1R12

Also known as Elliptic Laboratories ASA, Nykode Therapeutics ASANykode Therapeutics ASA

Elliptic Laboratories ASA

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation